This website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
This Website Uses Cookies By closing this message or continuing to use our site, you agree to our cookie policy. Learn MoreThis website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
Following the U.S. Food and Drug Administration’s (FDA’s) premarket approval of a cultured chicken meat product from UPSIDE Foods (also known as “cell-based” or “lab-grown” meat), U.S. and Chinese food safety regulatory officials conferred in an online event on the global adoption of cultivated meat and other innovative foods.
A recent China–Australia collaborative review examined similarities and differences in the food safety risk assessment systems of China, Australia and New Zealand, Canada, and the U.S., with the aim of identifying areas that could support improvements to the Chinese system.
A recent attribution analysis aimed to understand the epidemiological characteristics of foodborne illness outbreaks related to meat and meat products in China from 2002–2017.
The U.S. Food and Drug Administration (FDA) tested seafood samples for per- and polyfluoroalkyl substances (PFAS) and found harmful levels of perfluorooctanoic acid in canned clams from China.